Abstract

Introduction/BackgroundThe aim of the study was to evaluate the correlation between E-cadherin/β-catenin expression and the clinical and pathological parameters that influence the overall survival rate in patients with advanced stage...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Analysis of prognostic factors for overall survival in patients with advanced non-small cell lung cancer treated with second line chemotherapy
Tatjana Pejcic ... Marina Cekic
Advances in Lung Cancer | VOL. 02
Tatjana Pejcic, et. al.Tatjana Pejcic ... Marina Cekic
01 Jan 2013
1537P - Prognostic Factor for Survival in Patients with Advanced Thymic Carcinoma
Y. Nakahara ... Y. Hosomi
Annals of Oncology | VOL. 23
Y. Nakahara, et. al.Y. Nakahara ... Y. Hosomi
01 Sep 2012
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer
Tom Ehlen ... Antonio Casado
European Journal of Cancer | VOL. 47
Tom Ehlen, et. al.Tom Ehlen ... Antonio Casado
01 Sep 2011
1280 Survival impact of residual disease after primary debulking surgery in advanced-stage low grade serous ovarian cancer: a meta-analysis
Judicael Hotton ... Fabrice Lecuru
International Journal of Gynecologic Cancer | VOL. 34
Judicael Hotton, et. al.Judicael Hotton ... Fabrice Lecuru
01 Mar 2024
View more papers

More From: International Journal of Gynecologic Cancer

Paper Title
Journal
Date
Author
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)
Rita Trozzi ... Frédéric Amant
International Journal of Gynecologic Cancer | VOL. -
Rita Trozzi, et. al.Rita Trozzi ... Frédéric Amant
09 May 2024
Laparoscopic pancreatic peritonectomy with splenectomy for recurrent ovarian cancer: a novel approach to achieve R0 while preserving the pancreatic body and tail
Christina Vlamis ... Gary Altwerger
International Journal of Gynecologic Cancer | VOL. -
Christina Vlamis, et. al.Christina Vlamis ... Gary Altwerger
09 May 2024
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial
Alexander D Murphy ... Gordon C Jayson
International Journal of Gynecologic Cancer | VOL. -
Alexander D Murphy, et. al.Alexander D Murphy ... Gordon C Jayson
09 May 2024
Integrated histological parameters define prognostically relevant groups in atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia
Antonio Raffone ... Gian Franco Zannoni
International Journal of Gynecologic Cancer | VOL. -
Antonio Raffone, et. al.Antonio Raffone ... Gian Franco Zannoni
06 May 2024
View more papers